Scilex (SCLX) and Vera Therapeutics (VERA) Rise Premarket

Scilex (SCLX) and Vera Therapeutics (VERA) saw increases in premarket trading as strategic initiatives begin to gain traction. The market conditions appear favorable for SCLX, with notable trading activity suggesting investor interest. The developments may indicate potential for future growth, impacting market sentiment positively. Investors are keeping an eye on these moves as they assess the companies' performances and strategic decisions.